| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 78.7 | 115.5 |
| Profit before tax | -44.1 | 141.1 |
| Net income | -28.5 | 117.3 |
| EPS (diluted, $ a share) | $-1.43 | $5.68 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -31.8% |
|---|---|
| Operating margin | -20.0% |
10-Q filed with the SEC, NASDAQ: LGND. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Ligand Pharmaceuticals Inc: key numbers
- Share price
- $293.81Close, Nov 17
- Market cap
- $5.88B
- Shares outstanding
- 20MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Ligand Pharmaceuticals Inc
All →Ligand Pharmaceuticals Insider John W. Kozarich Sells $162K of Stock
John W. Kozarich sold 500 shares of Ligand Pharmaceuticals Inc at $325.00 a share, worth $162K in total on Nov 12, 2026. Shares held after the trade: 42,122 (-1.2%).
- Value
- $162K
- Shares
- 500
- Price
- $325.00
- Holding change
- -1.2%
- Trade date
- Nov 12, 2026
Ligand Pharmaceuticals Insider Martine Zimmermann Sells $636K of Stock
Martine Zimmermann sold 2,000 shares of Ligand Pharmaceuticals Inc at $318.17 a share, worth $636K in total on Nov 12, 2026. Shares held after the trade: 1,782 (-52.9%).
- Value
- $636K
- Shares
- 2,000
- Price
- $318.17
- Holding change
- -52.9%
- Trade date
- Nov 12, 2026
Ligand Pharmaceuticals Insider Jason Aryeh Sells $957K of Stock
Jason Aryeh sold 2,990 shares of Ligand Pharmaceuticals Inc at $319.99 to $320.20 a share (average $320.05) in 5 transactions, worth $957K in total on Nov 10, 2026. Shares held after the trade: 105,476 (-0.5%).
- Value
- $957K
- Shares
- 2,990
- Average price
- $320.05
- Holding change
- -0.5%
- Trade date
- Nov 10, 2026
Ligand Pharmaceuticals Insider Jason Aryeh Sells $90.2K of Stock
Jason Aryeh sold 282 shares of Ligand Pharmaceuticals Inc at $319.99 a share, worth $90.2K in total on Nov 4, 2026. Shares held after the trade: 108,476 (-0.3%).
- Value
- $90.2K
- Shares
- 282
- Price
- $319.99
- Holding change
- -0.3%
- Trade date
- Nov 4, 2026
Ligand Pharmaceuticals CLO & Secretary Andrew Reardon Sells $1.57M of Stock
Andrew Reardon, CLO & Secretary, sold 5,000 shares of Ligand Pharmaceuticals Inc at $307.39 to $323.14 a share (average $313.22) in 13 transactions, worth $1.57M in total on Nov 2, 2026. Shares held after the trade: 31,854 (-0.4%).
- Value
- $1.57M
- Shares
- 5,000
- Average price
- $313.22
- Role
- CLO & Secretary
- Holding change
- -0.4%
- Trade date
- Nov 2, 2026
Ligand Pharmaceuticals Insider Jason Aryeh Sells $676K of Stock
Jason Aryeh sold 2,111 shares of Ligand Pharmaceuticals Inc at $317.74 to $320.49 a share (average $320.30) in 6 transactions, worth $676K in total between Oct 30, 2026 and Nov 2, 2026. Shares held after the trade: 108,758 (-0.6%).
- Value
- $676K
- Shares
- 2,111
- Average price
- $320.30
- Holding change
- -0.6%
- Trade date
- Oct 30, 2026 to Nov 2, 2026